Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - Infusion Brands International, Inc. | v323312_8k.htm |
September 7, 2012
Securities and Exchange Commission
Washington, DC 20549
Commissioners:
We have read Item 4.01 of Solitron Devices, Inc.’s Form 8-K dated September 1, 2012, and we agree with such statements insofar as they relate to our firm and the predecessor firm, Meeks International, Inc.
/s/ Thomas, Howell, Ferguson, P.A
As successor to Meeks International, Inc.